Dovobet Ointment should not be used by anyone who has had a hypersensitivity reaction to either the active ingredients or any of the excipients. It is licensed for psoriasis vulgaris only and should not be used to treat erythrodermic, exfoliative or pustular psoriasis.
Dovobet Ointment should be avoided in any patient with a known calcium metabolism disorder. The corticosteroid content means it should be avoided in patients that have a rash caused by a virus (chickenpox, shingles, cold sores, etc.). Dovobet should also be avoided in patients where there is a likelihood of a fungal/bacterial infection or where the skin is broken.
A full list of contraindications and cautions is available by clicking here to access the full summary of product characteristics.